Skip to content

To study use of varunadi kwath in lower abdominal pain in sutika (Puerperal after pain).

Randomized controlled clinical study to evaluate the effect of varunadi kwath in the management of sutika makkala with special reference to puerperal after pain - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111925
Enrollment
70
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O908- Other complications of the puerperium, not elsewhere classified

Interventions

None listed

Sponsors

Dr Pooja Venkat Mane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed patient of Sutika Makkala within 5 days having lakshana Shool at basti nabhi udara region aadhman suchivat vedana at pakvashaya mutrasanga 2 Diagnosed patient of Sutika Makkala who had normal vaginal delivery

Exclusion criteria

Exclusion criteria: 1 Sutika with Cesarean section 2 Sutika with known case of HIV HbsAG positive 3 Sutika with PPH postpartum haemorrhage 4 Sutika with history of blood coagulapathy disorder 5 Sutika with history of haemoglobin less than 8gm% during pregnancy

Design outcomes

Primary

MeasureTime frame
Varunadi Kwath 50ml BD before meals for 5days will be effective in the management of Sutika Makkala with special reference to puerperal after painTimepoint: 5days

Secondary

MeasureTime frame
Varunadi kwath will be more effective than Ibuprofen tablet in the management of sutika makkalaTimepoint: 5days

Countries

India

Contacts

Public ContactDr Sachin Jagannath Patil

LRP ayurvedic medical college hospital post graduate institute and research centre Ishwarpur

sachinpatil5190@gmail.com9422407301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026